Nanoparticles loaded with bee venom kill HIV
(Medical Xpress)—Nanoparticles carrying a toxin found in bee venom can destroy human immunodeficiency virus (HIV) while leaving surrounding cells unharmed, researchers at Washington University School of ...
HIV & AIDS
Mar 08, 2013 |
5 / 5 (29) |
3
|
Researchers describe first 'functional HIV cure' in an infant
A team of researchers from Johns Hopkins Children's Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School describe the first case of a so-called "functional cure" in an HIV-infected ...
HIV & AIDS
Mar 03, 2013 |
5 / 5 (9) |
1
|
Drug helps purge hidden HIV virus, study shows
A team of researchers at the University of North Carolina at Chapel Hill have successfully flushed latent HIV infection from hiding, with a drug used to treat certain types of lymphoma.
HIV & AIDS
Mar 08, 2012 |
4.8 / 5 (5) |
0
Team develops mathematical model to measure hidden HIV
(Medical Xpress)—Scientists have long believed that measuring the amount of HIV in a person's blood is an indicator of whether the virus is actively reproducing. A University of Delaware-led research team ...
HIV & AIDS
May 08, 2013 |
5 / 5 (3) |
0
|
Researchers find potential novel treatment for influenza
An experimental drug has shown promise in treating influenza, preventing lung injury and death from the virus in preclinical studies, according to University of Maryland School of Medicine researchers publishing in the journal ...
Diseases, Conditions, Syndromes
May 01, 2013 |
4.3 / 5 (3) |
0
|
Study shows genital herpes can reactivate even during high dose antiviral therapy
A study combining three trials of antiviral therapy to treat genital herpes (herpes simplex virus type 2/HSV-2) has shown that the virus can reactivate in 'breakthrough episodes' even when doses of antiviral therapy are high. ...
Diseases, Conditions, Syndromes
Jan 04, 2012 |
5 / 5 (2) |
0
New drug stimulates immune system to kill infected cells in animal model of hepatitis B infection
A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of ...
Diseases, Conditions, Syndromes
Apr 26, 2013 |
4.5 / 5 (2) |
0
New ways viruses affect human immune response discovered
(Medical Xpress) -- New ways that viruses manipulate the human immune response have been revealed in a research paper just published in Nature involving TCD scientists. Dr Orla Mulhern and Professor Andrew Bowie, School of Bio ...
Immunology
Aug 03, 2012 |
5 / 5 (1) |
0
|
Antiviral therapy may halve risk of liver cancer after chronic hepatitis C infection
Treating chronic hepatitis C infection with antiviral drugs could halve the risk of developing the most common form of liver cancer, in some cases, indicates an analysis of the published research in one of the new BMJ Op ...
Diseases, Conditions, Syndromes
Oct 22, 2012 |
5 / 5 (1) |
0
Sustained virological response linked with improved survival for patients with chronic HCV infection
Among patients with chronic hepatitis C virus infection and advanced hepatic fibrosis (development of excess fibrous connective tissue), sustained virological response (SVR) to interferon-based treatment was associated with ...
Diseases, Conditions, Syndromes
Dec 25, 2012 |
5 / 5 (1) |
0
|
